Fundraising Fox
/Companies
Sign in

Fable

5 known investors

Find your way into Fable

Sign up to see every warm intro you have to Fable

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Fable team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Fable Therapeutics is a biotech company using protein engineering to develop biologics targeting the activin receptor type II (ActR2) pathway for obesity and related metabolic diseases. Its pipeline addresses body composition and broader metabolic health rather than weight loss alone, serving patients with obesity and cardiometabolic comorbidities.

BiotechHealthtechLongevity

Founders & leadership

GMGeoff MacKay
Geoff MacKayPresident & CEO
DB
David BakerChief Scientific Officer
RW
Rhonda WidemanChief Business Officer
ZM
Zack McNealyChief Financial Officer

Investors · 5

Versant Ventures✓ confirmed by FableSan Francisco · $250K – $5M

How we know: Versant Ventures's portfolio page · the company's own site · Not right? Tell us

DCVC Bio✓ confirmed by FablePalo Alto

How we know: the company's own site · Not right? Tell us

Lilly Asia Ventures✓ confirmed by FableHong Kong

How we know: the company's own site · Not right? Tell us

DCVC (Data Collective)reportedPalo Alto · $5M – $25M

How we know: the VCSheet dataset · Not right? Tell us

Related companies · 2

Applied TherapeuticsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.
Mission BioCapital Platinum Program Holdings LLCMission BioCapital is a venture capital firm that invests in early-stage life science companies, from therapeutics and drug discovery to biotech tools and diagnostics. The firm provides capital, operational support, and lab infrastructure through its MBC BioLabs co-working spaces to help scientific entrepreneurs launch and scale biotech startups.

Companies working in the same space as Fable.

Frequently asked questions

What does Fable do?
Fable Therapeutics is a biotech company using protein engineering to develop biologics targeting the activin receptor type II (ActR2) pathway for obesity and related metabolic diseases. Its pipeline addresses body composition and broader metabolic health rather than weight loss alone, serving patients with obesity and cardiometabolic comorbidities.
Who are Fable's investors?
Fable's investors include MPM BioImpact, Versant Ventures, DCVC Bio, Lilly Asia Ventures, DCVC (Data Collective).